Peter E. Lipsky
Ampel BioSolutions (United States)(US)KITE Research Institute
Publications by Year
Research Areas
T-cell and B-cell Immunology, Systemic Lupus Erythematosus Research, Immune Cell Function and Interaction, Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses
Most-Cited Works
- → Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis(2000)3,014 cited
- → Cyclooxygenase in biology and disease(1998)2,501 cited
- → Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial(1999)2,347 cited
- → Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation(2007)1,106 cited
- → Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid Arthritis(1999)803 cited
- → TNF downmodulates the function of human CD4+CD25hi T-regulatory cells(2006)767 cited